JPRN-UMIN000050997
Recruiting
Phase 2
Primary focal therapy for prostate cancer using low-dose-rate brachytherapy - Primary focal brachytherapy for prostate cancer
Saitama Cancer Center0 sites200 target enrollmentMay 7, 2023
Conditionsprostate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- prostate cancer
- Sponsor
- Saitama Cancer Center
- Enrollment
- 200
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) severe comorbidity 2\) history of radiation therapy to pelvic cavity
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
Salvage focal therapy for prostate cancer using low-dose-rate brachytherapyprostate cancerJPRN-UMIN000051113Saitama Cancer Center100
Completed
N/A
Focal therapy of localized prostate cancer using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technologyC61Malignant neoplasm of prostateDRKS00007105Klinik für Urologie, Universitätsmedizin Mannheim50
Recruiting
N/A
Focal therapy for locally recurrent prostate cancerprostate cancerJPRN-UMIN000038761Tokyo Medical and Dental University100
Recruiting
N/A
Focal Brachytherapy for localized prostate cancer diagnosed by saturation biopsyJPRN-UMIN000044790ara Medical University35
Not Yet Recruiting
N/A
Focal therapy of recurrent prostate cancer after external beam radiation therapy using mpMRI/TRUS-guided high intensity focused ultrasound (HIFU) technology (FOXPRO_RAD) – an initial pilot studyC61Malignant neoplasm of prostateDRKS00009020Klinik für Urologie, Universitätsmedizin Mannheim15